Miller Howard Investments’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $86.6M | Sell |
397,998
-3,294
| -0.8% | -$731K | 2.37% | 6 |
|
|
2025
Q4 | $91.7M | Sell |
401,292
-5,439
| -1% | -$1.24M | 2.77% | 5 |
|
|
2025
Q3 | $94.2M | Buy |
406,731
+1,009
| +0.2% | +$205K | 2.87% | 4 |
|
|
2025
Q2 | $75.3M | Buy |
405,722
+603
| +0.1% | +$112K | 2.39% | 8 |
|
|
2025
Q1 | $84.9M | Sell |
405,119
-4,034
| -1% | -$784K | 2.7% | 5 |
|
|
2024
Q4 | $72.7M | Sell |
409,153
-6,334
| -2% | -$1.16M | 2.39% | 11 |
|
|
2024
Q3 | $82.1M | Sell |
415,487
-35,183
| -8% | -$6.57M | 2.53% | 8 |
|
|
2024
Q2 | $77.3M | Sell |
450,670
-6,179
| -1% | -$1.02M | 2.56% | 4 |
|
|
2024
Q1 | $83.2M | Sell |
456,849
-6,544
| -1% | -$1.13M | 2.73% | 4 |
|
|
2023
Q4 | $71.8M | Sell |
463,393
-4,292
| -0.9% | -$626K | 2.5% | 5 |
|
|
2023
Q3 | $69.7M | Buy |
467,685
+4,152
| +0.9% | +$610K | 2.56% | 8 |
|
|
2023
Q2 | $62.5M | Buy |
463,533
+208
| +0% | +$30.5K | 2.22% | 14 |
|
|
2023
Q1 | $73.8M | Sell |
463,325
-20,004
| -4% | -$3.06M | 2.67% | 4 |
|
|
2022
Q4 | $78.1M | Sell |
483,329
-4,220
| -0.9% | -$647K | 2.83% | 2 |
|
|
2022
Q3 | $65.4M | Sell |
487,549
-123,626
| -20% | -$17.7M | 2.69% | 2 |
|
|
2022
Q2 | $93.6M | Buy |
611,175
+7,330
| +1% | +$1.12M | 3.62% | 1 |
|
|
2022
Q1 | $97.9M | Sell |
603,845
-10,179
| -2% | -$1.48M | 3.43% | 1 |
|
|
2021
Q4 | $83.1M | Buy |
614,024
+68,379
| +13% | +$8.08M | 3.07% | 3 |
|
|
2021
Q3 | $58.9M | Sell |
545,645
-20,211
| -4% | -$2.31M | 2.43% | 11 |
|
|
2021
Q2 | $63.7M | Buy |
565,856
+1,286
| +0.2% | +$145K | 2.55% | 6 |
|
|
2021
Q1 | $61.1M | Sell |
564,570
-10,869
| -2% | -$1.16M | 2.57% | 9 |
|
|
2020
Q4 | $61.7M | Sell |
575,439
-43,022
| -7% | -$4.13M | 2.91% | 6 |
|
|
2020
Q3 | $54.2M | Sell |
618,461
-16,401
| -3% | -$1.54M | 2.86% | 4 |
|
|
2020
Q2 | $62.3M | Buy |
634,862
+16,025
| +3% | +$1.41M | 3.11% | 1 |
|
|
2020
Q1 | $47.1M | Sell |
618,837
-97,534
| -14% | -$8.31M | 2.41% | 15 |
|
|
2019
Q4 | $63.4M | Sell |
716,371
-7,618
| -1% | -$632K | 1.99% | 26 |
|
|
2019
Q3 | $54.8M | Buy |
723,989
+601,270
| +490% | +$41.2M | 1.71% | 31 |
|
|
2019
Q2 | $8.92M | Buy |
+122,719
| New | +$9.65M | 0.26% | 60 |
|
|
2018
Q2 | – | Sell |
-698,697
| Closed | -$66.1M | – | 164 |
|
|
2018
Q1 | $66.1M | Sell |
698,697
-25,059
| -3% | -$2.75M | 1.56% | 29 |
|
|
2017
Q4 | $70M | Sell |
723,756
-59,305
| -8% | -$5.59M | 1.52% | 28 |
|
|
2017
Q3 | $69.6M | Sell |
783,061
-28,138
| -3% | -$2.14M | 1.43% | 30 |
|
|
2017
Q2 | $58.8M | Sell |
811,199
-242,100
| -23% | -$16.3M | 1.17% | 42 |
|
|
2017
Q1 | $68.6M | Sell |
1,053,299
-668,025
| -39% | -$42M | 1.32% | 28 |
|
|
2016
Q4 | $108M | Sell |
1,721,324
-88,398
| -5% | -$5.4M | 2.07% | 8 |
|
|
2016
Q3 | $114M | Sell |
1,809,722
-50,462
| -3% | -$3.27M | 2.1% | 11 |
|
|
2016
Q2 | $115M | Sell |
1,860,184
-84,988
| -4% | -$5.18M | 2.06% | 11 |
|
|
2016
Q1 | $111M | Sell |
1,945,172
-102,641
| -5% | -$5.72M | 2.06% | 11 |
|
|
2015
Q4 | $121M | Buy |
2,047,813
+506,666
| +33% | +$29.2M | 2.17% | 11 |
|
|
2015
Q3 | $83.9M | Sell |
1,541,147
-47,281
| -3% | -$3.08M | 1.39% | 24 |
|
|
2015
Q2 | $107M | Buy |
1,588,428
+277,960
| +21% | +$18.1M | 1.44% | 21 |
|
|
2015
Q1 | $76.7M | Buy |
1,310,468
+26,107
| +2% | +$1.58M | 1.16% | 30 |
|
|
2014
Q4 | $84M | Buy |
1,284,361
+33,554
| +3% | +$2.12M | 1.29% | 25 |
|
|
2014
Q3 | $72.2M | Buy |
+1,250,807
| New | +$69.4M | 1.12% | 27 |
|
Other funds holding ABBV
VCM
VPM
Miller Howard Investments's ABBV Position: Q1 2026 in Review
Miller Howard Investments reduced its AbbVie (ABBV) stake by 0.82% in Q1 2026, selling an estimated $731K and leaving 397,998 shares worth $86.6M. The position accounts for 2.37% of the portfolio, ranked #6.
Miller Howard Investments first reported a position in ABBV in Q3 2014 and has held it in 43 quarters since. The position peaked at $121M in Q4 2015. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Miller Howard Investments held 397,998 shares of AbbVie worth $86.6M as of Q1 2026.
- Miller Howard Investments sold 3,294 AbbVie shares in Q1 2026, an estimated $731K.
- AbbVie made up 2.37% of Miller Howard Investments's portfolio in Q1 2026, its #6 holding.
- Miller Howard Investments first reported a position in AbbVie in Q3 2014 and has held it in 43 quarters since.
- Miller Howard Investments's AbbVie position peaked at $121M in Q4 2015.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Miller Howard Investments's 13F filing for Q1 2026, filed 20 Apr 2026.